Research ArticleCancer Immunotherapy

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs

See allHide authors and affiliations

Sci. Signal.  17 Jan 2017:
Vol. 10, Issue 462, eaaf8608
DOI: 10.1126/scisignal.aaf8608

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article